Da Ren

Dr. Da Ren has been pioneering and leading the advancement and expansion of analytical platforms and strategies in the biopharmaceutical industry. He led the first-in-industry implementation of the Multi-Attribute Method (MAM) in QC, which largely optimizes the process efficiency and ensures quality with highly accurate and refined results meeting the regulatory requirements. MAM has been accepted by over 30 regulatory agencies around the world. Da is on the advisory board of a number of analytical technologies companies and serves multiple roles in industry-wide organizations including US Pharmacopeia, CASSS, ASMS, and MAM Consortium. He founded BioTherapeutics Solutions to bring innovative, comprehensive, and high quality analytical solutions to the biopharmaceutical industry. Prior to starting BioTherapeutics Solutions, he was a Scientific Director at Amgen in charge of analytical platforms and global strategy of MAM. Prior to Amgen, Da was a Senior Applications Chemist at Waters Corporation. He received his Ph.D. in Analytical Chemistry from the University of Akron in 2002.